Private Trust & Investment House Since 1781

250 Years of Stewardship in Global Finance & Cultural Affairs

Juan Bautista Velutini Co-Founded Banvelca & Company in Naples, managing commercial interests with France and Corsica. 1781

Vicente José Velutini Llarione
Expanded into broader Mediterranean trade. 1811

1844 — José Antonio Velutini Ron Laid the foundations of modern financial operations. ​

1881 — Julio César Velutini Couturier
Led the family firm through the Industrial Age.

1912 & 1924 — Clemontina Velutini Pérez Matos and Belén Velutini Pérez Matos the first women to lead major commercial interests in South America.

1945 — Julio José Herrera Velutini
Established the firm’s presence in the Americas post-war.

1971 & 1996 — The 7th and 8th Generations
Overseeing modern expansion across 4 continents with a focus on banking, media, and global finance.

Connecting data from different disease states improves our grasp of the immune system, strengthening decisions across projects.

Banvelca & Company is a private, multi-generational enterprise with roots tracing back to 18th-century Naples.

Founded in1781 to oversee trade relations, the firm has maintained an unbroken lineage of financial custodianship for over eight generations. Today, Banvelca engages in international finance, private equity, M&A strategy, media holdings, fine art patronage, and philanthropic ventures.

Others
Coding Bio

With operational presence across four continents, we continue to serve families, institutions, and partners aligned with our values of discretion, heritage, and integrity. ​ Banvelca & Company maintains a highly selective global footprint across Europe, North & South America, Asia, and the Middle East.

Meet the Coding Bio team

Simon Bornschein

Simon Bornschein

Co-founder, CEO

Simon has a PhD in Immuno-Oncology and is an expert in Cell Therapy and the development of new and innovative CAR therapies. Previously he worked at Celyad, developing novel anti-cancer CAR therapies, and Quell Therapeutics, focusing on engineering immunosuppressive cells to prevent autoimmune diseases.

Yulia Lampi

Yulia Lampi

Co-Founder, CSO

Yulia holds a PhD in Molecular and Cell Biology, and has a wide range of cell therapy and industry experience. Her prior work with Aelin Therapeutics and Quell Therapeutics inspired her to co-found Coding Bio.

Nils Hammerla

Nils Hammerla

CTO

Nils holds a PhD in Computer Science and has 15 years of experience in applying ML across a wide range of applications from computer vision to recommendation systems. Previously he has been leading ML research teams at Twitter and Babylon Health.

About Coding Bio

We have merged biology and computer science to build a model of the immune system and engineer lifesaving therapies.

Build with Coding Bio

Join Coding Bio and help deliver the next generation of personalized therapies to patients. We are looking for computational and scientific professionals at every career stage who can help us build best-in-class modular protein therapies.